Yuichi Hashimoto Selected Research

Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy)

1/2020

Application of protein knockdown strategy targeting β-sheet structure to multiple disease-associated polyglutamine proteins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuichi Hashimoto Research Topics

Disease

33	Alzheimer Disease (Alzheimer's Disease) 03/2022 - 02/2002
20	Neoplasms (Cancer) 01/2021 - 03/2002
7	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2022 - 03/2013
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2016 - 02/2006
5	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2021 - 03/2013
5	Leukemia 05/2015 - 12/2006
4	Dementia (Dementias) 01/2021 - 01/2008
4	Multiple Myeloma 05/2015 - 01/2008
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2008 - 11/2004
3	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2021 - 10/2010
3	Neuroblastoma 07/2012 - 10/2003
3	Diarrhea 12/2010 - 04/2008
3	Acute Promyelocytic Leukemia 07/2009 - 12/2002
3	Juvenile Amyotrophic Lateral Sclerosis 2 03/2008 - 04/2004
3	Amyloid Plaque 05/2006 - 09/2002
2	Carcinogenesis 01/2021 - 01/2009
2	Huntington Disease (Huntington's Disease) 01/2020 - 01/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 11/2016
2	Dyslipidemias (Dyslipidemia) 01/2017 - 11/2016
2	Inflammation (Inflammations) 01/2017 - 01/2008
2	Non-alcoholic Fatty Liver Disease 01/2017 - 05/2011
2	Inborn Genetic Diseases (Disease, Hereditary) 04/2016 - 09/2013
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2013 - 07/2009
2	progressive familial intrahepatic 1 Cholestasis 06/2012 - 05/2012
2	Infections 12/2010 - 07/2009
2	Carcinoma (Carcinomatosis) 04/2005 - 05/2002
1	Proteostasis Deficiencies 01/2021
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 01/2020
1	Cerebellar Ataxia (Dysmetria) 01/2020
1	Endometriosis 07/2018

Drug/Important Bio-Agent (IBA)

17	humaninIBA 09/2017 - 05/2002
15	Proteins (Proteins, Gene)FDA Link 03/2022 - 02/2002
10	Peptides (Polypeptides)IBA 01/2021 - 05/2002
8	Thalidomide (Thalomid)FDA Link 07/2010 - 12/2002
7	Pharmaceutical PreparationsIBA 01/2021 - 03/2002
5	CholesterolIBA 01/2020 - 07/2009
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017 - 12/2006
5	PresenilinsIBA 03/2012 - 02/2002
5	Amyloid beta-PeptidesIBA 05/2006 - 09/2002
4	LigandsIBA 01/2017 - 01/2008
4	Anesthetics (Anesthetic Agents)IBA 01/2017 - 02/2015
4	Amyloid (Amyloid Fibrils)IBA 06/2016 - 02/2002
4	Flavin-Adenine Dinucleotide (FAD)IBA 08/2004 - 02/2002
3	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2022 - 09/2017
3	Immunologic Factors (Immunomodulators)IBA 01/2021 - 12/2002
3	Biological ProductsIBA 05/2015 - 01/2008
3	AcidsIBA 05/2011 - 02/2006
3	Antiviral Agents (Antivirals)IBA 12/2010 - 07/2003
3	Androgen Receptors (Androgen Receptor)IBA 07/2008 - 05/2002
3	Superoxide Dismutase-1IBA 03/2008 - 02/2005
3	AndrogensIBA 04/2005 - 05/2002
2	Mutant Proteins (Protein, Mutant)IBA 01/2020 - 09/2013
2	Hormones (Hormone)IBA 07/2018 - 04/2014
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017 - 03/2013
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2017 - 01/2008
2	Liver X ReceptorsIBA 01/2017 - 07/2009
2	1'-acetoxychavicol acetateIBA 05/2015 - 10/2008
2	benzohydrol (benzhydrol)IBA 05/2015 - 10/2008
2	Phosphotransferases (Kinase)IBA 12/2014 - 02/2013
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 06/2014 - 11/2005
2	SteroidsIBA 05/2014 - 06/2009
2	TubulinIBA 12/2013 - 11/2002
2	Neuroprotective AgentsIBA 08/2013 - 11/2004
2	Calcitriol Receptors (Calcitriol Receptor)IBA 02/2013 - 06/2008
2	cellular retinoic acid binding protein IIIBA 07/2012 - 04/2010
2	Rhodopsin (Visual Purple)IBA 03/2011 - 10/2010
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 02/2009 - 09/2008
2	TeaIBA 02/2009 - 09/2008
2	PyrrolesIBA 07/2008 - 04/2005
2	2- (2,6- diisopropylphenyl)- 5- hydroxy- 1H- isoindole- 1,3- dioneIBA 02/2008 - 01/2008
2	Glucose (Dextrose)FDA LinkGeneric 01/2008 - 08/2007
2	LipidsIBA 01/2008 - 08/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2007 - 12/2006
2	PPAR alphaIBA 12/2006 - 02/2006
2	ColivelinIBA 01/2006 - 11/2005
2	activity-dependent neurotrophic factorIBA 11/2005 - 11/2004
2	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 11/2005 - 04/2004
2	AminopeptidasesIBA 09/2004 - 04/2003
2	Presenilin-2IBA 08/2004 - 03/2002
2	Insulin-Like Growth Factor I (IGF-1)IBA 04/2004 - 02/2004
2	Pertussis ToxinIBA 03/2002 - 02/2002
1	diazonaphthalenedisulfonic acid (NDS)IBA 03/2022
1	AminesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	CollagenIBA 01/2021
1	2- amino- 6- methyldipyrido(1,2- a- 3',2'- d)imidazoleIBA 01/2021
1	AdiponectinIBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	polyglutamineIBA 01/2020
1	OxysterolsIBA 01/2020
1	atrophin-1IBA 01/2020
1	Ataxin-7IBA 01/2020
1	Ataxin-3IBA 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2018
1	Contraceptive Agents (Contraceptives)IBA 07/2018

Therapy/Procedure

9	Therapeutics 01/2020 - 12/2002
3	General Anesthesia 04/2016 - 02/2015
3	Cesarean Section (Caesarean Section) 04/2016 - 06/2013
3	Drug Therapy (Chemotherapy) 01/2013 - 01/2008
1	Subcutaneous Injections 01/2021